Announcements Trials
Browse Landscape

Phase

Phase NA 3

Status

Unknown 25Recruiting 18Completed 15Not yet recruiting 8Active not recruiting 5Withdrawn 3Terminated 3Suspended 2

Sponsor Class

OTHER 3

Study Type

Interventional 3

Sponsor

Cancer Type

Gastrointestinal 3Endocrine 1

Conditions

Stomach Neoplasms 1Esophageal Neoplasms 1Colorectal Adenoma With Mild Dysplasia 1Barrett Esophagus 1

Interventions

Fluorouracil 145Gemcitabine 141Oxaliplatin 135Capecitabine 133Leucovorin 107Irinotecan 99Bevacizumab 92Cetuximab 69Cisplatin 67pembrolizumab 61Radiotherapy 60Nivolumab 41130-nm albumin-bound paclitaxel 41Sorafenib 39Docetaxel 34Albumin-Bound Paclitaxel 31Radiosurgery 28Paclitaxel 27Surgical Procedures, Operative 25regorafenib 24Erlotinib Hydrochloride 23Panitumumab 22Cyclophosphamide 21Celecoxib 20Trastuzumab 19Radiation 18Neoadjuvant Therapy 18IFL protocol 18atezolizumab 17Carboplatin 17

Date Range

30 days90 days1 yearAll

Options

Has results Has announcements

Clinical Trials

3 trials
RecentStart dateEnrollment
Terminated × Endoscopic Mucosal Resection × Gastrointestinal × Clear all
NCT04977401 2023-10-23

EPSILON

Erasme University Hospital

Phase NA Terminated
32 enrolled
Gastrointestinal

Stomach Neoplasms

NCT02238938 2023-06-29

PERLA

Universitätsklinikum Hamburg-Eppendorf

Phase NA Terminated
110 enrolled
Gastrointestinal

Colorectal Adenoma With Mild Dysplasia

NCT01572987 2017-05-30

ERADICATE

Midwest Veterans' Biomedical Research Foundation

Phase NA Terminated
12 enrolled
Gastrointestinal

Barrett Esophagus, Esophageal Neoplasms

Data powered by HemOnc (CC BY 4.0) Colophon âš¡